Search

Chemoradiotherapy (CRT) followed by consolidation immune checkpoint inhibitors significantly improves survival in unresectable locally advanced non-small cell lung cancer. However, the optimal sequence for CRT and immune checkpoint inhibitors has not yet been established. We investigated the dynamics of peripheral blood immune cells during CRT to determine the best sequence for treatment.Peripheral blood samples were prospectively collected pretreatment, weekly during CRT for 6 weeks, and 1 month posttreatment in 24 patients with locally advanced non-small cell lung cancer who received definitive CRT. Immune cell analysis was performed by flow cytometry. Ex vivo PD-1 blockade assays were performed by IFN-γ intracellular cytokine staining.Lymphopenia was prominently observed during CRT and mostly recovered 1 month post-CRT. Robust proliferation of CD8The findings suggest that earlier administration of PD-1 blockade may be associated with superior efficacy compared with delayed administration after completion of CRT. These findings provide an immunologic rationale for optimal timing of combining immune checkpoint inhibitors with CRT in clinical trials.

We report on the development of a highly flexible, thin shape sensor that can be integrated into minimally invasive surgery systems. Three optical fibers are arranged in a triangular shape and epoxy molded to produce a sensor diameter of less than 900 μm, ensuring high-bending operation up to 90°. Each fiber contains four fiber Bragg gratings (FBGs) operating at different wavelengths. With simultaneous detection of all the grating signals, the overall curvatures and torsions are interpolated and used for three-dimensional shape reconstruction. Three FBGs located at the same axial location also enables temperature compensation. Real-time shape monitoring with a sampling rate of 3.74 Hz is realized. The average tip position error was 1.50% of the total sensor length.